Caterina Cristinelli
@CCristinelli
Followers
45
Following
151
Statuses
41
Lympho-Hematologist @HopSaintLouis, @APHP, Paris - France
Parigi, Francia
Joined August 2014
RT @Roberta04704608: 2nd day of preceptorship on lymphomas today! @HopSaintLouis @muséedesmoulages. Toxicities of #cartcell , #nuclearmedic…
0
7
0
RT @Roberta04704608: So glad to welcome Mexican colleagues for 2025 edition of @HopSaintLouis Preceptorship on lymphomas! Day one of our fo…
0
4
0
RT @ComeBommier: @HopSaintLouis au top 👌 19,25/20. Jamais eu une aussi bonne note de ma vie. #1 dans la catégorie lymphome-myélome…
0
2
0
Another important step in understanding pathogenesis of CD 🔬is out today : “Interleukin‐6 transcripts up‐regulation in lymph nodes from unicentric and multicentric Castleman disease” - Lucioni - eJHaem - Wiley Online Library
0
1
2
RT @BloodAdvances: The rules of T-cell engagement: current state of CAR T cells and bispecific antibodies in B-cell lymphomas https://t.co/…
0
11
0
RT @EHA_Hematology: Today’s #ehaThinkingThursday is on latest recommendations for first-line treatment of Chronic Lymphocytic #Leukemia and…
0
7
0
RT @ComeBommier: Jamais simple de revenir de vacances, mais quel bonheur de retrouver @HopSaintLouis et la formidable équipe d’hémato-onc…
0
1
0
Really beautiful exchange on new therapies in #DLBCL 🇧🇷
Fantastic 2-day discussion on new strategies in DLBCL with colleagues and friends from Brazil! @HopSaintLouis @CancerParisNord @univ_paris_cite
0
0
5
RT @HopSaintLouis: [#Presse] Les CAR-T parviennent à éradiquer certaines tumeurs🎙️« cette thérapie cellulaire révolutionne la prise en char…
0
13
0
RT @CwynKate: Current and upcoming treatment approaches to uncommon subtypes of PTCL (EATL/MEITL, SPTCL, HSTCL)
0
14
0
Axicabtagene ciloleucel versus standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume
0
0
4
RT @SFParisRugby: Le Sport Santé, c'est CAPITAL ! A l’occasion de la 𝑱𝒐𝒖𝒓𝒏𝒆́𝒆 𝑴𝒐𝒏𝒅𝒊𝒂𝒍𝒆 𝒅𝒆 𝒍𝒂 𝑺𝒂𝒏𝒕𝒆́, le @SFParisRugby soutient le financem…
0
18
0
RT @WomenInLymphoma: *TODAY* ⚕️#WiLingWednesdays free educational webinars 🩺#DLBCL👉🏽4pm EDT🇺🇸/10pm CEST🇫🇷🇪🇸/7am Thur AEDT🇦🇺 🔗 https://t.co…
0
4
0
RT @merli_michele: Just out in @BrJHaem! Very happy to share our last work exploring molecular landscape of HCV+ DLBCL @luca_arcaini @CCris…
0
7
0
RT @tobyeyre82: Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma https…
0
37
0
RT @majorajay: For all you #lymsm nerds (and heme/onc fellows!) out there, check out our #ASH23 Education Program review on how we sequence…
0
10
0
RT @NEJM: Original Article: CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up Editoria…
0
54
0
RT @lymphomahub: CONGRESS | #CART24 | @c_thieblemont of @HopSaintLouis reports the longer 3-year follow-up data from the phase 2 ELARA tri…
0
13
0
RT @lymphomahub: CONGRESS | #CART24 | @Roberta04704608 @HopSaintLouis discusses intensive care management strategies with CAR T-cell thera…
0
12
0
